SPARC can test Rs 90: Tater

Sun Pharma Advanced Research Company (SPARC) can test Rs 90, says Ashish Tater of Fort Share Broking.

Tater told CNBC-TV18, "Sun Pharma Advance Research Company (SPARC), is a one company that we are extremely bullish on with a theme of 2012-2013. The stock with the market battering has broken its support levels but now has again found support close to that Rs 70-72 mark and we feel the stock can easily go back to that Rs 90 levels in next 30-40 trading sessions." He further added, "I am playing this particular stock with a day target of close to Rs 76. However, this is one company that will hog limelight in 2012 once the patent in NDDS (New Drug Delivery System) division of the company delivers with a longer-term view, we can have this stock into one